Egg Allergy Market Players, Trends, Analysis, Segmentation and Forecast till 2030

Egg Allergy Market

The egg allergy market is anticipated to reach USD 2016.43 Million by 2030 at 6.90% CAGR during the forecast period 2022-2030.

Egg allergy is caused by a protein in eggs which triggers an abnormal reaction to the immune system such as rash, vomiting, eczema, stomach pain, wheezing, runny nose, nausea, and in rare cases, anaphylaxis. Egg allergy is very common in children and tends to outgrow with age, even though in some cases, egg allergy may persist for a lifetime. Recent studies indicate that egg allergy has become more persistent than previously believed.  According to the report published by, McGill University in2016, egg allergy is common in infants and young children and affects 1 to 2% of the preschool children. Such a rise in incidences of egg allergies increase the demand for diagnostic tests and medications and spur the growth of the global egg allergy market. Egg allergy diagnosis procedures have shown noteworthy developments such as skin test and blood tests which have become easy and time-saving. For instance, in August 2018, Creative Diagnostics has developed a set of humanized monoclonal antibodies (IgM, IgG or IgA) that can be used as calibrators, positive, negative, or quality controls in assay development and manufacturing of diagnostic kits. Conversely, the growth of the global egg allergy market might be hampered by a lack of awareness regarding egg allergy. In developing countries, people are negligent towards egg allergies and tend to avoid treatment and diagnosis for the same which limits the market growth in such regions. Also, poor healthcare infrastructure and inaccessibility restrain market growth. Also, allergy detection tests such as blood tests and skin tests are expensive, and a small error in the procedure can cause huge loss. Skin tests cost around USD 60 to 300 while blood tests can go up to USD 200 to 1000 which cannot be afforded by everyone. Furthermore, allergy tests are not generally covered under health insurance policies. Thus, unfavorable reimbursement policies and high costs associated with allergy diagnostic tests constrain the growth of the market to a large extent. Technological advancements in screening procedures provide favorable backgrounds for the growth of the market while technical difficulties associated with them are likely to pose a challenge for the market growth.

Major Key Players:

Mylan N.V. (US), Genetech, Inc. (US), Sanofi (France), Creative Diagnostics (US), Alletess Medical Laboratory (US), HYCOR Biomedical (US), Kaleo, Inc. (US), Impax Laboratories, Inc (US), Kaleo, Inc. (US), Quest Diagnostics (US), Impax Laboratories (US), Imutest Ltd. (UK), and ImmuneTech (US) are the Egg Allergy Market Players.

Segment Analysis

The Global Egg Allergy Market has been segmented based on age group, diagnosis & treatment, and end user.

By age group, the Global Egg Allergy Market has been segmented into children (0-18 years and adults (18+ years).

By diagnosis & treatment, the global egg allergy market has been segmented into diagnosis and treatment. The diagnosis segment has been further segmented into skin test, blood test, food challenge, and others.  The treatment segment has been further segmented into medication and oral immunotherapy. The medication sub-segment has been further segmented into antihistamine, epinephrine, and others.

By end user, the Global Egg Allergy Market has been segmented into hospitals & clinics, diagnostic centers, research institutes, and others.

Regional Analysis

Regionally, the Global Egg Allergy Market is spanned across the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa. The Global Egg Allergy Market is dominated by the Americas which has been further segmented into North America and South America. North America accounts for the maximum share of the North America market. Government support in the form of favorable legislation, coupled with the concentration of prominent market players in the region aid the growth of the market. Europe is the second largest market for egg allergy. Increasing prevalence of egg allergy in the region is a prime factor in boosting the market growth in Europe. The European Academy of Allergy and Clinical Immunology (EAACI) estimates that the number of people suffering from food allergy has increased to 17 Million in the last ten years which generates considerable demand for diagnosis and treatment. Besides, rigorous R&D efforts and high expenditure on healthcare could drive the market in Europe.

APAC is poised to emerge as the fastest growing market for egg allergy at a CAGR of 8.71% over the forecast period. Growing innovation in the field of allergen-free food products, growing awareness, and faster adoption of new technologies spur the market in APAC. The MEA market is anticipated to register a CAGR of 5.70% over the forecast period due to limited access to healthcare in the developing countries. However, the Middle East market is likely to showcase moderate growth on account of improving healthcare infrastructure.
About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Nanobody Market Expected to Reach 2.94 billion by 2032, Driven by Superior Targeting and Efficacy

  According to MRFR analysis, the global  nanobody market  is expected to register a CAGR of 17.88% from 2023 to 2032 and hold a value of over USD 2.94 billion by 2032 In recent years, the field of biotechnology has witnessed a transformative breakthrough with the advent of nanobodies and Nanobody technology. Nanobodies, also known as VHH antibodies or single-domain antibodies, are small antigen-binding fragments derived from camelid heavy-chain antibodies. Their unique properties have positioned them as powerful tools in various applications, ranging from therapeutic drug development to diagnostics and imaging. Nanobody technology harnesses the potential of these small, robust antibody fragments. Unlike traditional antibodies, nanobodies are compact, stable, and exhibit superior tissue penetration, making them ideal candidates for therapeutic interventions. Their single-domain structure allows for precise targeting of specific antigens, minimizing off-target effects and enhancing ther
Read more

US Physician Groups Market Growth with a CAGR of 5.80% to Reach USD 524.1 Billion by 2032

  The  US Physician Groups Market  is expected to reach USD 524.1 Billion by 2032 at 5.80% CAGR during the forecast period 2023-2032. The US Physician Groups market is a dynamic and essential component of the country's healthcare system, comprising a diverse range of medical professionals dedicated to providing primary care services. Among these healthcare providers, the role of the family physician stands out prominently. Family doctors play a pivotal role in delivering comprehensive healthcare to individuals and families, acting as primary points of contact for a wide array of medical concerns. Physician groups in the United States have evolved to meet the growing demand for accessible and personalized healthcare. The emphasis on preventive care and holistic well-being has elevated the significance of family physicians within these groups. These healthcare professionals are trained to address a broad spectrum of medical issues, from routine check-ups to managing chronic condition
Read more

Needle Biopsy Market is expected to Generate Huge Profits by 2030: Vendors- Boston Scientific Corporation, Cook Medical, CareFusion Corporation

  The  Needle Biopsy Market  is expected to reach USD 24,421.3 Million by 2030 at 12.5% CAGR during the forecast period. The Needle Biopsy market is experiencing significant growth and innovation, driven by advancements in medical technology and an increasing prevalence of cancer cases globally. This market overview focuses on two crucial components within the sector - Aspiration Needles and Biopsy Devices. Aspiration Needles play a pivotal role in obtaining tissue samples for diagnostic purposes. These needles are designed to aspirate fluids or collect tissue specimens with precision, aiding in the accurate diagnosis of various medical conditions, especially cancer. The demand for Aspiration Needles has surged due to their minimally invasive nature, allowing for quicker recovery times and reduced patient discomfort. Biopsy Devices are integral tools in the diagnostic landscape, enabling healthcare professionals to extract tissue samples for in-depth analysis. These devices have witnes
Read more